Homeβ€ΊSearchβ€ΊStrahlentherapie und Onkologie

Strahlentherapie und Onkologie

Urban und Vogel Β· Germany Β· Est. 1912

ISSN0179-7158eISSN1439-099X
SJR Q2βœ“ WOS SCIEβœ“ Scopus / SJR
96
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (3 more)+18
Total96
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
158
days submission β†’ published
measured Β· last 16 articles Β· accept 114d
Q2
SJR Rank
Top 50% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q2. Source: Clarivate Journal Citation Reports.

SJR Scorei
0.769
H-Indexi
89
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
0.87
Total Worksi
4,264
Total Citationsi
71,668
2yr Mean Citednessi
2.00
Open Impact Factor alternative

Aims & Scope

Strahlentherapie und Onkologie covers all aspects of oncology, with a focus on radiooncology, radiation biology and radiation physics. Founded in 1912 and the official publication of the German Society of Radiation Oncology (DEGRO), Austrian Society of Radiation Oncology (Γ–GRO), and the Scientific Association of Swiss Radiation Oncology (SASRO). Forum for radiooncologists and physicians interested in oncology, as well as radiation biologists and radiation physicists Publishes English language original articles, reviews and case studies, scientific short communications and literature reviews that inform the reader of new developments

General Information

Country / RegionGermany
Primary LanguageEnglish
1st Year Published1912
FrequencyMonthly
StatusActive
Total Publications4,264
Publisher OrgSpringer Science+Business Media
Visit Journal Website

Submission Info

Publishing ModelHybrid
Peer Reviewβ€”
Review Timeβ€”
Acceptance Rateβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
⚑ Hybrid journal β€” subscription model available.

Think.Check.Submit Compliance

6/12 Β· 50%
βœ…
Do you know the journal / publisher?
Urban und Vogel
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
0179-7158 / 1439-099X
βœ…
Indexed in a trusted database?
WoS, Scopus
❌
Peer review process documented?
N/A
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
❌
Plagiarism detection in place?
N/A
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
146
2.3k
2019
165
2.9k
2020
154
1.2k
2021
149
1.3k
2022
149
883
2023
151
593
2024
157
223
2025
68
1
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

OncologyQ2
Radiology, Nuclear Medicine and ImagingQ2

Subject Classification

Web of Science Categories

OncologyRadiology, Nuclear Medicine & Medical Imaging

Scopus Categories

Radiology, Nuclear Medicine and ImagingOncology

Research Topics (OpenAlex)

Advanced Radiotherapy TechniquesHead and Neck Cancer StudiesLung Cancer Diagnosis and TreatmentBrain Metastases and TreatmentGlioma Diagnosis and Treatment

Frequently asked questions about Strahlentherapie und Onkologie

Is Strahlentherapie und Onkologie a predatory journal?

PubScope has no integrity flags on record for Strahlentherapie und Onkologie: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Strahlentherapie und Onkologie?

Strahlentherapie und Onkologie is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 2.00.

Is Strahlentherapie und Onkologie indexed in Scopus and Web of Science?

Strahlentherapie und Onkologie is indexed in Web of Science, Scopus.

What is the aims and scope of Strahlentherapie und Onkologie?

Strahlentherapie und Onkologie covers all aspects of oncology, with a focus on radiooncology, radiation biology and radiation physics. Founded in 1912 and the official publication of the German Society of Radiation Oncology (DEGRO), Austrian Society of Radiation Oncology (Γ–GRO), and the Scientific Association of Swiss Radiation Oncology (SASRO). Forum for radiooncologists and physicians interested in oncology, as well as radiation biologists and radiation physicists Publishes English language original articles, reviews and case studies, scientific short communications and literature reviews th

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref